Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The expanding family of regulatory B cells.Int Immunol. 2015; 27: 479-486
- Antibody-independent functions of B cells: a focus on cytokines.Nat Rev Immunol. 2015; 15: 441-451
- Effector and regulatory B cells: modulators of CD4+ T cell immunity.Nat Rev Immunol. 2010; 10: 236-247
- Pathogenic functions of B cells in autoimmune diseases: IFN-gamma production joins the criminal gang.Eur J Immunol. 2015; 45: 966-970
- Identification of IFN-γ-producing innate B cells.Cell Res. 2014; 24: 161-176
- Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice.J Clin Invest. 2011; 121: 3645-3656
- B regulatory cells in cancer.Trends Immunol. 2013; 34: 169-173
- Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.Blood. 2011; 117: 530-541
- Identification of a B cell signature associated with renal transplant tolerance in humans.J Clin Invest. 2010; 120: 1836-1847
- Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans.J Clin Invest. 2010; 120: 1848-1861
- Immunologic human renal allograft injury associates with an altered IL-10/TNF-α expression ratio in regulatory B cells.J Am Soc Nephrol. 2014; 25: 1575-1585
- Tolerant kidney transplant patients produce B cells with regulatory properties.J Am Soc Nephrol. 2015; 26: 2588-2598
- Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype.Kidney Int. 2010; 78: 503-513
- A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus.Immunity. 2016; 44: 683-697
- Characterisation of allergen-specific responses of IL-10-producing regulatory B cells (Br1) in Cow Milk Allergy.Cell Immunol. 2010; 264: 143-149
- Regulatory B cell frequency correlates with markers of HIV disease progression and attenuates anti-HIV CD8+ T cell function in vitro.J Leukoc Biol. 2013; 93: 811-818
- CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.Immunity. 2010; 32: 129-140
- Cytokine-producing B cells: a translational view on their roles in human and mouse autoimmune diseases.Immunol Rev. 2016; 269: 130-144
- TLR and B cell receptor signals to B cells differentially program primary and memory Th1 responses to Salmonella enterica.J Immunol. 2010; 185: 2783-2789
- B cells expressing IFN-gamma suppress Treg-cell differentiation and promote autoimmune experimental arthritis.Eur J Immunol. 2015; 45: 988-998
- Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment.Arthritis Rheum. 2008; 58: 1566-1575
- The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment.J Autoimmun. 2014; 50: 67-76
- B cell immunobiology in disease: evolving concepts from the clinic.Annu Rev Immunol. 2006; 24: 467-496
- Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice.J Clin Invest. 2007; 117: 3857-3867
- Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.N Engl J Med. 2004; 350: 2572-2581
- Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice.Proc Natl Acad Sci U S A. 2007; 104: 20878-20883
- Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression.J Clin Invest. 2008; 118: 3420-3430
- Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial.Lancet Neurol. 2014; 13: 353-363
- Am"B"valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis.Blood. 2010; 116: 515-521
- Regulatory B cells as inhibitors of immune responses and inflammation.Immunol Rev. 2008; 224: 201-214
- B-cell-depleting induction therapy and acute cellular rejection.N Engl J Med. 2009; 360: 2683-2685
- CD19 expression in B cells is important for suppression of contact hypersensitivity.Am J Pathol. 2007; 171: 560-570
- Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation.Immunity. 2002; 16: 219-230
- B cells regulate autoimmunity by provision of IL-10.Nat Immunol. 2002; 3: 944-950
- A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses.Immunity. 2008; 28: 639-650
- Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells.Int J Cancer. 2005; 117: 574-586
- B cells inhibit induction of T cell-dependent tumor immunity.Nat Med. 1998; 4: 627-630
- B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice.J Immunol. 2010; 184: 4006-4016
- The role of B cells for in vivo T cell responses to a Friend virus-induced leukemia.Science. 1990; 249: 921-923
- CD20+ B cells: the other tumor-infiltrating lymphocytes.J Immunol. 2010; 185: 4977-4982
- Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?.Ann Neurol. 2010; 67: 452-461
- Human transitional B cell T1/T2 ratio is a new marker for allograft deteriotration in kidney transplant recipients.Kidney Int. 2017; 91 (*denotes equal contribution): 183-195
- Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice.J Immunol. 2009; 182: 3492-3502
- Transcriptomics identify CD9 as a marker of murine IL-10-competent regulatory B cells.Cell Rep. 2015; 13: 1110-1117
- TIM-4 identifies IFN-gamma-expressing proinflammatory B effector 1 cells that promote tumor and allograft rejection.J Immunol. 2017; 199: 2585-2595
- Tim-1 is essential for induction and maintenance of IL-10 in regulatory B cells and their regulation of tissue inflammation.J Immunol. 2015; 194: 1602-1608
- TIM-1 signaling is required for maintenance and induction of regulatory B cells.Am J Transplant. 2015; 15: 942-953
- Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation.Immunity. 2014; 41: 1040-1051
- IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.Nature. 2014; 507: 366-370
- Regulation of IFN-gamma production by B effector 1 cells: essential roles for T-bet and the IFN-gamma receptor.J Immunol. 2005; 174: 6781-6790
- Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cells.Nat Immunol. 2013; 14: 514-522
- Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus.Immunity. 2009; 30: 421-433
- B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.J Exp Med. 2012; 209: 1001-1010
- B cells mediate chronic allograft rejection independently of antibody production.J Clin Invest. 2014; 124: 1052-1056
- Human regulatory B cells in health and disease: therapeutic potential.J Clin Invest. 2017; 127: 772-779
- IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses.J Allergy Clin Immunol. 2013; 131: 1204-1212
- TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients.Arthritis Res Ther. 2017; 19: 8
- Expression of tumor necrosis factor receptor 2 characterizes TLR9-driven formation of interleukin-10-producing B cells.Front Immunol. 2017; 8: 1951
- Human "orchestrator" CD11b(+) B1 cells spontaneously secrete interleukin-10 and regulate T-cell activity.Mol Med. 2012; 18: 1003-1008
- Unique B cell differentiation profile in tolerant kidney transplant patients.Am J Transplant. 2014; 14: 144-155
- IL-10-produced by human transitional B-cells down-regulates CD86 expression on B-cells leading to inhibition of CD4+T-cell responses.Sci Rep. 2016; 6: 20044
- Increased CD40 ligation and reduced BCR signalling leads to higher IL-10 production in B cells from tolerant kidney transplant patients.Transplantation. 2017; 101: 541-547
- Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients.Am J Transplant. 2015; 15: 2908-2920
- Biomarkers of tolerance in kidney transplantation: are we predicting tolerance or response to immunosuppressive treatment?.Am J Transplant. 2016; 16: 3443-3457
- Signatures of tolerance or immunosuppression?.Am J Transplant. 2016; 16: 3320-3321
- Rituximab induction and risk of cardiac allograft vasculopathy, rejection and death.J Heart Lung Transplant. 2017; 36: S88
- Rituximab and intravenous immune globulin for desensitization during renal transplantation.N Engl J Med. 2008; 359: 242-251
- Reconstitution of peripheral allospecific CD19+ B-cell subsets after B-lymphocyte depletion therapy in renal transplant patients.Transplantation. 2009; 87: 1394-1401
- Renal transplant recipients treated with calcineurin-inhibitors lack circulating immature transitional CD19+CD24hiCD38hi regulatory B-lymphocytes.PLoS One. 2016; 11: e0153170
- Transitional B lymphocytes are associated with protection from kidney allograft rejection: a prospective study.Am J Transplant. 2015; 15: 1384-1391
- Dynamic changes of B-cell compartments in kidney transplantation: lack of transitional B cells is associated with allograft rejection.Transpl Int. 2016; 29: 540-548
- An analysis of lymphocyte phenotype after steroid avoidance with either alemtuzumab or basiliximab induction in renal transplantation.Am J Transplant. 2012; 12: 919-931
- Prospective analyses of circulating B cell subsets in ABO-compatible and ABO-incompatible kidney transplant recipients.Am J Transplant. 2017; 17: 542-550
- B cells display an abnormal distribution and an impaired suppressive function in patients with chronic antibody-mediated rejection.Kidney Int. 2014; 85: 590-599
- Reduced human transitional B cell T1/T2 ratio is associated with subsequent deterioration in renal allograft function.Kidney Int. 2017; 91: 183-195
- Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD.Blood. 2014; 124: 2034-2045
- IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation.Blood. 2016; 128: 1346-1361
- B cell repopulation after alemtuzumab induction-transient increase in transitional B cells and long-term dominance of naive B cells.Am J Transplant. 2012; 12: 1784-1792
- In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development.J Immunol. 2013; 191: 2818-2828
- Effect of different induction strategies on effector, regulatory and memory lymphocyte sub-populations in clinical islet transplantation.Transpl Int. 2009; 22: 182-191
- The effect of low and ultra-low dosages Thymoglobulin on peripheral T, B and NK cells in kidney transplant recipients.Transpl Immunol. 2012; 26: 186-190
- Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways.Transplantation. 2005; 79: 1507-1515
- Dynamic analysis of B-cell subsets in de novo living related kidney transplantation with induction therapy of basiliximab.Transplant Proc. 2014; 46: 363-367
- In vitro effects of rituximab on the proliferation, activation and differentiation of human B cells.Am J Transplant. 2012; 12: 341-350
- To B or not to B? Glucocorticoid impact on B lymphocyte fate and function.Endocrinology. 2014; 155: 339-342
- Immunoglobulin production induced in vitro by glucocorticoid hormones: T cell-dependent stimulation of immunoglobulin production without B cell proliferation in cultures of human peripheral blood lymphocytes.J Clin Invest. 1981; 68: 1539-1547
- Activation of human B lymphocytes. IV. Regulatory effects of corticosteroids on the triggering signal in the plaque-forming cell response of human peripheral blood B lymphocytes to polyclonal activation.J Immunol. 1977; 119: 598-603
- Effects of sotrastaurin, mycophenolic acid and everolimus on human B-lymphocyte function and activation.Transpl Int. 2012; 25: 1106-1116
- Transient low-dose methotrexate generates B regulatory cells that mediate antigen-specific tolerance to alglucosidase alfa.J Immunol. 2014; 193: 3947-3958
- Calcineurin and mTOR inhibitors have opposing effects on regulatory T cells while reducing regulatory B cell populations in kidney transplant recipients.Transpl Immunol. 2016; 35: 1-6
- Kidney transplant recipients treated with belatacept exhibit increased naïve and transitional B cells.Am J Transplant. 2014; 14: 1173-1182
- Immunophenotyping of peripheral immunoregulatory as well as Th17A and Th22 cell subpopulations in kidney transplant recipients under belatacept or cyclosporine treatment.Transpl Immunol. 2014; 30: 107-113
- Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial.Lancet. 2018; https://doi.org/10.1016/S0140-6736(18)30984-X
- Anti-CD45RB/anti-TIM-1-induced tolerance requires regulatory B cells.Am J Transplant. 2012; 12: 2072-2078
- Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells.Proc Natl Acad Sci U S A. 2007; 104: 14080-14085
- The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals.J Immunol. 2009; 182: 7459-7472
- IFN-β treatment requires B cells for efficacy in neuroautoimmunity.J Immunol. 2015; 194: 2110-2116
- Laquinimod modulates B cells and their regulatory effects on T cells in multiple sclerosis.J Neuroimmunol. 2012; 251: 45-54
- Fingolimod treatment promotes regulatory phenotype and function of B cells.Ann Clin Transl Neurol. 2015; 2: 119-130
- Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy.Clin Exp Rheumatol. 2011; 29: 697-700
- Interleukin-6: from identification of the cytokine to development of targeted treatments.Joint Bone Spine. 2010; 77: 532-536
- Regulatory B cells in rheumatoid arthritis: alterations in patients receiving anti-TNF therapy.Clin Immunol. 2017; 184: 63-69
- Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks.J Immunol. 2008; 180: 688-692
- Etanercept attenuates collagen-induced arthritis by modulating the association between BAFFR expression and the production of splenic memory B cells.Pharmacol Res. 2013; 68: 38-45
- 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells.Eur J Immunol. 2008; 38: 2210-2218
- Involvement of suppressive B-lymphocytes in the mechanism of tolerogenic dendritic cell reversal of type 1 diabetes in NOD mice.PLoS One. 2014; 9: e83575
- Regulatory B cells are induced by gut microbiota-driven interleukin-1β and interleukin-6 production.Nat Med. 2014; 20: 1334-1339
- Interleukin-35 induces regulatory B cells that suppress autoimmune disease.Nat Med. 2014; 20: 633-641
- Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions.Nature. 2012; 491: 264-268
Article info
Publication history
Published online: December 17, 2018
Footnotes
Disclosure Statement: Dr. Rothstein get fund support from NIH grants AI114587 , AI129880 and American Society of Transplantation TIRN grant on Biomarker Discovery and Validation.
Identification
Copyright
© 2018 Elsevier Inc. All rights reserved.
